Market Tracker

06/22 12:21pm ET

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

43.15
BATS BZX Real-Time Price
As of 12:19pm ET
 +0.40 / +0.94%
Today’s Change
17.25
Today|||52-Week Range
43.45
+70.89%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close42.75
Today’s open42.90
Day’s range42.90 - 43.45
Volume9,006
Average volume (3 months)628,120
Market cap$2.1B
Dividend yield--
Data as of 12:19pm ET, 06/22/2017

Growth & Valuation

Earnings growth (last year)+528.57%
Earnings growth (this year)-36.25%
Earnings growth (next 5 years)+27.00%
Revenue growth (last year)+48.87%
P/E ratio23.1
Price/Sales6.07
Price/Book11.14

Competitors

 Today’s
change
Today’s
% change
PRTAProthena Corporation...+0.31+0.55%
TBPHTheravance Biopharma...-0.22-0.54%
PTLAPortola Pharmaceutic...-0.46-1.16%
LOXOLoxo Oncology Inc+2.78+3.59%
Data as of 12:20pm ET, 06/22/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)$0.27
Annual revenue (last year)$215.0M
Annual profit (last year)$91.2M
Net profit margin42.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Secretary &
Director
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts